Prescription Opioid Use among Adults with Mental Health Disorders in the United States

References

1. 1.↵
   Centers for Disease Control and Prevention. 2011. Understanding the epidemic: drug overdose deaths in the United States continue to increase in 2015. Updated December 16, 2016. Available from: http://www.cdc.gov/drugoverdose/epidemic/. Accessed December 15, 2016.
2. 2.↵
   1. Rudd RA,
   2. Aleshire N,
   3. Zibbell JE,
   4. Gladden RM

   . Increases in drug and opioid overdose deaths–United States, 2000–2014. MMWR Morb Mortal Wkly Rep 2016;64:1378–82.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Helmerhorst GT,
   2. Vranceanu AM,
   3. Vrahas M,
   4. Smith M,
   5. Ring D

   . Risk factors for continued opioid use one to two months after surgery for musculoskeletal trauma. J Bone Joint Surg Am 2014;96:495–9.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Inacio MC,
   2. Hansen C,
   3. Pratt NL,
   4. Graves SE,
   5. Roughead EE

   . Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open 2016;6:e010664.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Goesling J,
   2. Henry MJ,
   3. Moser SE,
   4. et al

   . Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain 2015;16:844–51.

   OpenUrl
6. 6.↵
   1. Sullivan MD,
   2. Edlund MJ,
   3. Zhang L,
   4. Unutzer J,
   5. Wells KB

   . Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006;166:2087–93.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Seal KH,
   2. Shi Y,
   3. Cohen G,
   4. et al

   . Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012;307:940–7.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Halbert BT,
   2. Davis RB,
   3. Wee CC

   . Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain 2016;157:2452–7.

   OpenUrl
9. 9.↵
   1. Bair MJ,
   2. Robinson RL,
   3. Katon W,
   4. Kroenke K

   . Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433–45.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Currie SR,
    2. Wang J

    . Chronic back pain and major depression in the general Canadian population. Pain 2004;107:54–60.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    Centers for Disease Control and Prevention. Burden of mental illness. Last reviewed July 1, 2011; last updated October 4, 2013; Available from: https://www.cdc.gov/mentalhealth/basics/burden.htm. Accessed September 15, 2016.
12. 12.↵
    1. Cohen JW,
    2. Cohen SB,
    3. Banthin JS

    . The Medical Expenditure Panel Survey: a national information resource to support healthcare cost research and inform policy and practice. Med Care 2009;47 (7 Suppl 1):S44–50.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Guevara JP,
    2. Mandell DS,
    3. Rostain AL,
    4. Zhao H,
    5. Hadley TR

    . National estimates of health services expenditures for children with behavioral disorders: an analysis of the medical expenditure panel survey. Pediatrics 2003;112(6 Pt 1):e440.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    Cerner Corporation. Cerner Multum drug database. Available from: http://www.cerner.com/cerner_multum/. Accessed December 15, 2016.
15. 15.↵
    Agency for Healthcare Research and Quality. Healthcare Utilization Project. Clinical Classification Software for ICD-9-CM. Last modified March 6, 2017. Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed December 15, 2016.
16. 16.↵
    1. Ware J Jr.,
    2. Kosinski M,
    3. Keller SD

    . A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. DeSalvo KB,
    2. Bloser N,
    3. Reynolds K,
    4. He J,
    5. Muntner P

    . Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med 2006;21:267–75.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Charlson ME,
    2. Pompei P,
    3. Ales KL,
    4. MacKenzie CR

    . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. D'Hoore W,
    2. Bouckaert A,
    3. Tilquin C

    . Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol 1996;49:1429–33.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Gaskin DJ,
    2. Richard P

    . The economic costs of pain in the United States. J Pain 2012;13:715–24.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Chou R,
    2. Gordon DB,
    3. de Leon-Casasola OA,
    4. et al

    . Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016;17:131–57.

    OpenUrlPubMed
22. 22.↵
    1. Dowell D,
    2. Haegerich TM,
    3. Chou R

    . CDC Guideline for prescribing opioids for chronic pain–United States, 2016. JAMA 2016;315:1624–45.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Turk DC,
    2. Okifuji A

    . What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain 1997;13:330–6.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Cochran BN,
    2. Flentje A,
    3. Heck NC,
    4. et al

    . Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend 2014;138:202–8.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Park TW,
    2. Lin LA,
    3. Hosanagar A,
    4. Kogowski A,
    5. Paige K,
    6. Bohnert AS

    . Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy. J Addict Med 2016;10:369–81.

    OpenUrl
26. 26.↵
    Task Force on Taxonomy of the International Association for the Study of Pain. Classification of Chronic Pain. Seattle (WA): IASP Press; 1994.
27. 27.↵
    1. Scherrer JF,
    2. Salas J,
    3. Copeland LA,
    4. et al

    . Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain 2016;17:473–82.

    OpenUrl
28. 28.↵
    1. Kroenke K,
    2. Wu J,
    3. Bair MJ,
    4. Krebs EE,
    5. Damush TM,
    6. Tu W

    . Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain 2011;12:964–73.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Kroenke K,
    2. Bair MJ,
    3. Damush TM,
    4. et al

    . Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009;301:2099–110.

    OpenUrlCrossRefPubMed